To investigate the role of ATP-sensitive K' channels in modulating the efferent autonomic response following close at physiological intracellular concentrations of ATP but open when the ATP concentration decreases.8 Drugs that open K' channels, such as pinacidil, enhance the KATP channel current,9-12 whereas sulfonylurea drugs, glibenclamide and tolbutamide, selectively block KATP channels.13-'5 A reduction in action potential duration during ischemia/hypoxia is accompanied by a decrease in contraction,7'16 which is a major step consuming ATP.17 Shortening of action potential duration during ischemia/hypoxia by enhancement of KATP channel current18'9 would reduce the Ca21 current associated with accelerating loss of contractile activity7,20 and might prevent further depletion of ATP and protect the cells from irreversible ischemic injury.8'21 Some data suggest that activation of KATP channels reduces myocardial damage caused by ischemia/reperfusion. [22] [23] [24] Recently, KATP channels have been demonstrated in mammalian neurons.25 However, little is known about the relation between autonomic denervation during ischemia/infarction and KATP channels. Because activation of KATP channels appears to reduce myocardial 380
acute myocardial ischemia/infarction, we examined the effects of a blocker (glibenclamide) and an opener (pinacidil) of ATP-sensitive K' channels on the time course and extent of the attenuation in efferent cardiac sympathetic responsiveness in anesthetized dogs. We measured the effective refractory periods (ERPs) at nonischemic sites basal and apical to the area of myocardial ischemia/infarction in the baseline state and during bilateral stimulation of the ansae subclaviae before and after each drug administration and 5, 30, 60, 120, and 180 minutes after latex injection of a diagonal branch of the left anterior descending coronary artery. Animals received either vehicle (n= 12), glibenclamide (0.3 mg * kg-1, n= 10), pinacidil (0.15 mg* kg-1+0.2 mg* kg-1 infusion, n=10), or a combination of these two drugs (n=9) intravenously. In another group of dogs receiving just pinacidil (n= 10), an intra-aortic balloon was inflated distal to the renal arteries to prevent pinacidilinduced hypotension. Another group of dogs received either high-dose glibenclamide (0.3 mg * kg-l +0.15 mg * kg-1, n=4), low-dose glibenclamide (0.06 mg * kg-1, n=4), medium-dose pinacidil (0.03 mg * kg-1+0.04 mg * kg-1 infusion, n=4), or low-dose pinacidil (0.0075 mg* kg-1+0.01 mg* kg-1 infusion, n=4). In all dogs, basal sites exhibited no attenuation of sympathetically induced shortening of the ERP throughout the period of acute myocardial ischemia/infarction. Cumulative attenuation in sympathetic responsiveness (shortening of ERP .2 milliseconds induced by bilateral stimulation of the ansae subclaviae) at nonischemic test sites apical to the area of ischemia/infarction during a 3-hour period was greater in the glibenclamide group (26 of 44 sites, P=.008) and less in the pinacidil (2 of 44 sites, P=.002) and pinacidil-balloon (1 of 48 sites, P<.001) groups compared with the vehicle group (14 of 46 sites). Glibenclamide abolished the protective effect of pinacidil so that 10 of 45 sites had <2-millisecond shortening during a 3-hour period in the glibenclamide+pinacidil group (P=.018 versus pinacidil group, P=.286 versus vehicle group). Such effects of glibenclamide and pinacidil on sympathetic attenuation were dose dependent. Maintaining the blood glucose level during glibenclamide administration did not affect the sympathetic attenuation after acute coronary artery occlusion. Infarct size using triphenyltetrazolium staining and measured as the ratio of the width of subepicardial infarction to the left ventricular circumference was similar (P>.9) among the five groups. Glibenclamide and pinacidil did not affect the attenuation of the ERP response to stimulation of the ansae subclaviae during pericardial superfusion with combined (12 mmol/L K+, pH 6.8, plus 10 ,umol/L adenosine) Tyrode's solution, suggesting no direct effects of glibenclamide and pinacidil on sympathetic neural function. We interpret these data to indicate that pinacidil helps preserve the ERP response to sympathetic stimulation during acute myocardial ischemia/infarction, whereas glibenclamide worsens it. (Circ Res. 1994; 75:379-392.) Key Words * denervation * efferent sympathetic nervemyocardial infarction * glibenclamide * pinacidil A cute transmural myocardial ischemia/infarction in the anesthetized dog causes efferent sympathetic and vagal denervation of nonischemic myocardium situated apical to the site of ischemia/infarction.1-3 Efferent sympathetic and vagal denervation develops heterogeneously and gradually over the first several hours3 and may contribute to electrical heterogeneity that can facilitate the development of ventricular tachyarrhythmias.2 Such neural dysfunction early after the onset of ischemia is a functional phenomenon unrelated to structural changes3 and can be reduced by multiple brief periods of ischemia4 (preconditioning5).
Myocardial ischemia or hypoxia decreases cardiac action potential duration,6'7 at least in part, because of the activation of ATP-sensitive K' (KATP) channels8 that damage during ischemia,2224 we hypothesized that pinacidil, but not glibenclamide, would preserve sympathetic innervation during myocardial ischemia. The purpose of the present study was to test this hypothesis by determining (1) whether a drug that opens the KATP channels reduces the attenuation of sympathetic responsiveness during acute coronary occlusion (2) and whether a drug that closes the KATP channels increases the attenuation of sympathetic responsiveness.
Materials and Methods

Surgical Procedures
Mongrel dogs (n= 101) of either sex were premedicated with morphine sulfate (2 mg. kg`1 IM) and anesthetized with thiopental (20 mg kg`1 IV). Anesthesia was maintained with a-chloralose (75 mg. kg-1+20 mg -kg1. h`1 IV). The dogs were ventilated by means of a cuffed endotracheal tube and volume-cycled respirator (model 607, Harvard Apparatus). A fluid-filled catheter was inserted in the thoracic aorta through the left femoral artery and connected to a transducer (Statham P-23Db, Gould) to monitor arterial blood pressure. The right and the left femoral veins were cannulated for drug administration and infusion of normal saline at 100 to 200 mL* h`1 to replace spontaneous fluid losses. Lead II of the electrocardiogram was monitored throughout the study. The chest was opened through a median sternotomy covered by a plastic sheet. Dogs were placed on a heating pad, and an operating room table lamp was used to maintain epicardial temperature at 36°C to 38°C. A thermistor (model 400, Yellow Springs Instrument) was used to monitor epicardial temperature. Arterial blood gases and pH were monitored and maintained within the physiological range. Blood glucose was measured by the oxidase-peroxidase enzyme reaction method. The ansae subclaviae were isolated bilaterally as they exited from the stellate ganglia, doubly ligated, and cut. The cervical vagi were also isolated bilaterally, doubly ligated, and transected.
In dogs assigned to protocols 1, 2, and 3 (see below), the heart was suspended in a pericardial cradle. The sinus node was crushed, and the heart was paced at a cycle length of 600 milliseconds from electrodes sutured to the right atrial appendage. Crushing the sinus node does not affect innervation to the ventricle.26 A diagonal branch of the left anterior descending coronary artery was isolated for later occlusion with latex just before the placement of plunge electrodes. Careful isolation of coronary arteries does not affect efferent sympathetic responsiveness.1 Fig 1 shows the position of hook electrodes for measuring effective refractory periods (ERPs). Two hook electrodes were placed in the midmyocardium basal to the isolated diagonal branch, and four to five additional electrodes were inserted in the midmyocardium apical to the isolated diagonal branch (Fig 1) . The electrodes served as the cathode for unipolar stimulation to determine ERPs. The anode was a 33-mm-diameter metal disk in the abdominal wall. A bipolar plunge electrode was also inserted in the myocardium of the left ventricle basal to the isolated diagonal branch to record a ventricular electrogram. Data were recorded beginning 30 minutes after the placement of the plunge electrodes.
In the dogs assigned to protocol 4, the pericardial cradling technique was modified to permit instillation of various solutions into the pericardial cavity to bathe the epicardial surface of the heart.2728 Through the pericardial opening, five to six plunge electrodes were inserted in the midmyocardium of the left ventricle to a depth of 4 to 6 mm for ERP determination.
Measurement of ERP
The ERP was determined at each electrode site by the extrastimulus technique by use of a programmable stimulator (Krannert Medical Engineering) and a constant-current isola-FIG 1. Diagram of the heart, indicating sites of electrode placement (o). Two electrodes for unipolar stimulation were placed basal to sites of ischemia/infarction (stippled area) produced by latex injection into a diagonal branch of the left anterior descending coronary artery. Four to five additional electrodes were placed apically. AO indicates aorta; LA, left atrial appendage; LAD, left anterior descending coronary artery; PA, pulmonary artery; RA, right atrial appendage; RV, right ventricle; and LV, left ventricle.
tor. Each ventricular test site was driven with a 2-millisecond rectangular stimulus twice the diastolic threshold, which was measured during each intervention. A train of eight stimuli (S1) was followed by a late premature stimulus (S2) that produced a propagated ventricular response. The Si-Si interval was 300 milliseconds in protocols 1, 2, and 3 and 250 milliseconds in protocol 4 and was kept constant throughout the experiment. The S1-S2 interval was shortened in steps of 2 milliseconds until S2 failed to produce a propagated ventricular response. The S1-S2 interval was then increased by 5 milliseconds and was shortened by 1-millisecond decrements until S2 failed to produce a propagated ventricular response. The ERP was defined as the longest S1-S2 interval at which S2 failed to produce a propagated response. The ERP was determined twice, and values were within 1 millisecond of each 20 minutes after each drug administration and 5, 30, 60, 120, and 180 minutes after coronary artery occlusion produced by latex injection. Ten minutes after the last stimulation of the ansae subclaviae, ERP during constant norepinephrine (NE) infusion was obtained. In another group, balloon inflation distal to the renal arteries was performed to prevent pinacidil-induced hypotension. In this group, systolic arterial pressure was maintained at the control value, and the rest of the protocol was the same as in the group just receiving pinacidil.
other, or the data were discarded and the determination was repeated. Each set of ERP determinations took =15 minutes.
Neural Stimulation
Shielded bipolar electrodes were placed on the right and left anterior and posterior ansae subclaviae to stimulate the efferent cardiac sympathetic nerves with a stimulator (model SD9, Grass Instrument Co). Stimuli were rectangular 4-millisecond pulses, and voltage was 5 to 8 V. Stimulation frequency was 4 Hz in protocol 1 and 2 to 4 Hz in protocol 2. Determination of the ERP was started 2 minutes after the onset of stimulation of the ansae subclaviae.
Determination of Extent of Myocardial Infarction
At the conclusion of the experiment, the heart was fibrillated and excised with the electrodes still in place. The left ventricle was cut in slices from base to apex. Each slice was stained with 2,3,5-triphenyltetrazolium chloride (TTC) in phosphate buffer29 to confirm the presence of transmural myocardial infarction that would affect subepicardial sympathetic neurons. 30 It was important to know the extent of epicardial involvement, because cardiac sympathetic fibers are distributed in the subepicardial layer.1,31'32 Therefore, the subepicardial width of the transmural myocardial infarction and the diameter of the left ventricle were measured in each Graph showing sympathetic attenuation in dogs with transmural myocardial infarction. Cumulative percentage of sympathetically nonresponsive apical sites is shown on the ordinate as a function of time after coronary artery occlusion produced by latex injection. Data were from 12 dogs in the vehicle group, 10 dogs in the glibenclamide group, 10 dogs in the pinacidil group, 9 dogs in the glibenclamide+pinacidil group, and 10 dogs in the pinacidil-balloon group. Numbers outside the parentheses indicate the cumulative number of nonresponsive test sites (total number of test sites that showed shortening of effective refractory period of <2 milliseconds at least once by that moment of determination); numbers in parentheses indicate the number of test sites that showed nonresponsiveness at that particular time of determination. The cumulative percentage of nonresponsive apical test sites was significantly higher (P=.008) in the glibenclamide group and less in the pinacidil group (P=.002) and the pinacidil-balloon group (P<.001) than in the vehicle group. The cumulative percentage of nonresponsive apical sites was significantly higher in the glibenclamide+pinacidil group than in the pinacidil group (P<.01 8) . There was no significant difference between the vehicle and glibenclamide+pinacidil groups.
slice. The width of the subepicardial infarction was determined as a percentage of the epicardial circumference of the left ventricle in each slice, and the greatest value was selected to represent the involvement of infarction in each dog, as reported previously.3 Although this method may not accurately provide an estimate of the total amount of infarcted myocardium, it was more important to know the extent of epicardial involvement that may have affected subepicardial sympathetic nerves for the purpose of the present study.
Chemicals and Drugs
Glibenclamide was purchased from Sigma Chemical Co as the free base. Pinacidil was a gift from Lilly Research Laboratories, Eli Lilly and Co. Glibenclamide was dissolved in a 1 :4 mixture of polyethylene-glycol and NaHCO3 (0.05 mol/L) to make a stock solution. 33 The stock solution of pinacidil was made with ethanol (35% [vol/vol]) and 2N HCl (1.75% [vol/ vol]).34 Each drug was diluted with normal saline or Tyrode's solution immediately before using.
Solutions
The composition of the normal Tyrode's solution (NT) was (mmol/L) NaCl 137.0, KCl 4.0, MgCl2 0.5, CaCl2 2.0, NaH2PO4 1.8, NaHCO3 18.0, and glucose 5.0. The composition of the combined Tyrode's solution (CT) was (mmol/L) NaCl 150.0, KCl 12.0, MgCl2 0.5, CaCl2 2.0, NaH2PO4 1.8, NaHCO3 5.5, glucose 5.0, and adenosine 0.01. The solutions were prewarmed in a heating bath to 36°C to 38°C and gassed with 95% 02/5% C02; resultant Po2 was 400 to 500 mm Hg, and the pH was 7.35 to 7.45 in NT and 6.75 to 6.85 in CT.
Protocols Protocol 1: Effects of Glibenclamide and Pinacidil on ERP Response to Stimulation of Ansae Subclaviae After Myocardial Infarction
The experimental design is illustrated in Fig 2. Thirty minutes after insertion of the plunge electrodes, ERPs were determined at baseline and during bilateral stimulation of the ansae subclaviae. Ten minutes after obtaining the baseline values, the dogs were given either vehicle (solvent for stock solution of glibenclamide [1:4 mixture of polyethylene-glycol and 50 mmol/L NaHCO3] and saline; total volume, 10 mL), glibenclamide (0.3 mg. kg`11V35), pinacidil (0.15 mg kg-1 IV+0.2 mg * kg-1 . h-1 during the study), or both glibenclamide and pinacidil (0.3 mg* kg-1 IV glibenclamide and 0.15 mg* kg-1 IV+0.2 mg* kg`h-1 pinacidil during the study).
This dose of pinacidil was slightly less than that reported previously in conscious dogs (0.21 to 0.24 ug * kg`1 min-1)36,37 but lowered the mean arterial blood pressure by 15 to 25 mm Hg in our preliminary study. The blood concentration of pinacidil is :0.4 ,umol/L with this amount of mean arterial blood pressure reduction,38 while ventricular ERP is unchanged. 39 The constant drug infusions were continued for the entire period of coronary occlusion.
Twenty minutes after each drug administration, ERPs at baseline and during bilateral stimulation of the ansae subclaviae were determined. Then 10 minutes after obtaining the ERPs, coronary artery occlusion was performed by latex injection. The isolated diagonal branch of the left anterior descending coronary artery was cannulated with a Teflon catheter (diameter, 0.8 to 1.1 mm; Desert Medical Inc), and 0.1 to 0.2 mL latex solution was injected to produce transmural myocardial infarction as in our previous studies.1-3 The ERPs were determined at 5, 30, 60, 120, and 180 minutes after coronary artery occlusion produced by latex injection before and during bilateral stimulation of the ansae subclaviae. After the determination of ERPs 180 minutes after coronary artery occlusion, norepinephrine was infused continuously at a dose of 0.25 jig. kg`. min-1, and ERPs were determined.
In another group of dogs, to prevent pinacidil-induced hypotension, a balloon catheter was introduced via the right femoral artery and positioned distal to the renal arteries before coronary artery occlusion. Systolic arterial blood pressure was maintained at the control value by use of a partial balloon inflation before and during coronary occlusion. The doses of pinacidil and the protocol were the same as in the other group of dogs receiving pinacidil but without a balloon catheter. In this group of dogs, a catheter was placed in the left atrium via the left atrial appendage, and left atrial pressure was recorded. Arterial blood gases and plasma K' were measured before and after the balloon inflation.
Sympathetically induced ERP shortening (1AERP) served as the measure of sympathetic responsiveness. The time course and extent of efferent sympathetic responsiveness over a 3-hour period of sustained coronary artery occlusion were compared in the five groups of dogs. We determined ERP responses at basal sites that remained innervated and at apical sites that became denervated. Although sites within the myocardial infarction can also become denervated,40 it is difficult to separate a lack of sympathetic responsiveness from a lack of response due to myocardial inexcitability caused by the ischemia/infarction.41 Hence, we measured AERP in nonischemic sites apical to the infarction zone. apical test sites before and after coronary artery occlusion in five groups of dogs. In each group, AERP at basal sites was not attenuated after drug administration (D) or during a 3-hour period after coronary artery occlusion produced by latex injection compared with control values (C). AERP at apical sites was not attenuated after each drug administration but became attenuated 5 minutes after coronary artery occlusion and declined further thereafter (P<.001 vs control values). However, the degree of attenuation of AERP after coronary artery occlusion was different among the five groups (see also Fig 5) . AERP induced by NE infusion 3 hours after coronary artery occlusion was similar in apical and basal sites in each group (far right in each panel). Data are expressed as mean--SEM. *Significantly different from control value within each group (P<.001).
0.3 mg* kg`1 IV+0.15 mg * kg-1 h`1 IV (high-dose) glibenclamide, 0.06 mg kg`1 IV (low-dose) glibenclamide, 0.03 mg* kg`1 IV+0.04 mg* kg`1 * h`1 during the study (mediumdose) pinacidil, or 0.0075 mg kg`1 IV+0.01 mg kg`1 h`1 during the study (low-dose) pinacidil. The protocol was the same as in the group of dogs that received glibenclamide or pinacidil in protocol 1. In the high-dose glibenclamide group, glibenclamide was added each hour. Constant infusion of pinacidil was maintained during the entire period of coronary artery occlusion in the medium-and low-dose pinacidil group. ERP determination during norepinephrine infusion was not performed at the end of the study in these four groups.
Protocol 3: Effects of Glibenclamide With Glucose Infusion on ERP Response to Stimulation ofAnsae Subclaviae After Myocardial Infarction
Hypoglycemia increases the myocardial ischemic injury and accelerates myocardial necrosis. 42 Hypoglycemia also reduces electrical activity in the nervous system43 and may affect the ERP response induced by stimulation of the ansae subclaviae. To test whether glibenclamide-induced hypoglycemia affected the ERP response to stimulation of the ansae subclaviae after myocardial ischemia/infarction, we infused the 20% glucose solution into the right femoral vein at a constant rate (glucose infusion rate was from 1.5 to 3.7 mg* kg`min-1) to maintain a normal blood glucose concentration after glibenclamide injection (0.3 mg* kg-1). The protocol was the same as in the group of dogs receiving just 0.3 mg* kg-1 glibenclamide in protocol 1. ERP determination during norepinephrine infusion at the end of the study was not obtained in this group.
Protocol 4: Effects of Epicardial Superfusion With Glibenclamide and Pinacidil on ERP Response to Stimulation ofAnsae Subclaviae
Because KATP channels have recently been demonstrated in mammalian neurons, 25 it was important to test whether KATP channel modulators had direct effects on efferent sympathetic function in control and during simulated ischemia produced by high K', low pH, and adenosine as reported previously.28 Therefore, we determined the effects of epicardial superfusion with glibenclamide and pinacidil on ERP response to stimulation of the ansae subclaviae by instilling each drug into the pericardial cavity for 60 minutes at a constant rate of 15 to 20 mL min-1 by use of a peristaltic pump. The drug was then removed from the pericardial sac by suction. Control dogs received three instillations of NT; test dogs received instillations of NT, test solution, and the NT again, separated by 10-minute intervals. Test solutions were NT with 1 ,umol/L glibenclamide, NT with 1 gmol/L pinacidil, CT (see solutions), CT with 1 ,mol/L glibenclamide, and CT with 1 ,mol/L pinacidil.
Analysis of Data
Sites were considered to be sympathetically nonresponsive if bilateral stimulation of the ansae subclaviae shortened the ERP >9 milliseconds before coronary artery occlusion but . milliseconds on at least one occasion after coronary occlusion.,3 Sites with <9-millisecond AERP during bilateral stimulation of the ansae subclaviae before each drug administration or control epicardial superfusion with NT were excluded because of possible insufficient effects of neural stimulation for accurate detection of sympathetic nonresponsiveness. In protocols 1, 2, and 3, data from 10 of 82 dogs were excluded from analysis because of nontransmural myocardial infarction (7 dogs). Data were excluded from 1 dog in which all apical test sites were found to be located in the infarction zone as determined by TTC stain, from 1 dog with marked hypotension after pinacidil (systolic arterial pressure, <80 mm Hg), and from 1 dog with frequent episodes of ventricular fibrillation after coronary artery occlusion. Nineteen of 307 apical test sites and 2 of 144 basal sites in 72 dogs were located in the myocardial infarction zone by TTC stain and were excluded from analysis. Ventricular fibrillation occurred in 5 dogs (1 in the vehicle group 30 minutes after coronary artery occlusion, 2 in the glibenclamide+pinacidil group, 1 in the pinacidil-balloon group, and 1 in the low-dose glibenclamide group 5 minutes after coronary artery occlusion) during the determination of ERP. ERP data points were not obtained at these times.
Statistical Analysis
Data are expressed as mean+SEM. Comparisons of control values and of infarct size between groups were made with one-way ANOVA. Differences between groups over time in ERP, hemodynamics, and blood glucose were compared by using two-way repeated-measures ANOVA. One-way repeated-measures ANOVA and the Newman-Keuls test were used to compare time trends within groups or changes among epicardial superfusions. Differences from vehicle within corresponding time values were compared by using one-way ANOVA and Tukey's honestly significant difference or Duncan's multiple range test. Cumulative percentage of sympathetically nonresponsive sites was compared by using the Lee-Desu statistics. Statistical significance was set at P<.05.
Results
Protocol 1: Effects of Glibenclamide and Pinacidil on ERP Response to Stimulation of Ansae Subclaviae After Myocardial Infarction
Baseline ERP values before stimulation of the ansae subclaviae are shown in Table 1 . Neither glibenclamide, pinacidil, nor a combination of these two drugs exerted a significant effect on baseline ERP values either at basal or apical test sites. Baseline ERP values at apical sites shortened slightly over time after latex injection, as we have noted earlier. 3 The cumulative percentage of sympathetically nonresponsive apical sites was significantly greater in the glibenclamide group (P=.008) and less in the pinacidil group (P=.002) and pinacidil-balloon group (total number of test sites that showed shortening of effective refractory period .2 milliseconds at least once by that moment of determination); the numbers in parentheses indicate the number of test sites that showed nonresponsiveness at that particular time of determination. The cumulative percentage of nonresponsive apical sites was similar among glibenclamide, high-dose glibenclamide, and glibenclamide+glucose groups. The cumulative percentage of nonresponsive apical sites in the low-dose glibenclamide group was similar to that in the vehicle group. The format is as in Fig 3. sponsiveness in the glibenclamide+pinacidil group was similar to that in the vehicle group (P=.286) but was higher than in the pinacidil group (P=.018) and less than in the glibenclamide group (P<.001) (Fig 3) . No basal sites in the five groups became sympathetically nonresponsive after drug administration or after coronary artery occlusion (not shown). Fig 4 shows AERP induced by bilateral stimulation of the ansae subclaviae at all basal and apical test sites. Before coronary artery occlusion, glibenclamide or pinacidil did not significantly affect the AERP induced by bilateral stimulation of the ansae subclaviae at sites basal or apical to the ischemia/infarction. In each group, ZvERP at apical sites was reduced 5 minutes after latex injection and continued to decline throughout ischemia/infarction (P<.001), whereas it remained unchanged at basal sites. AERP induced by norepinephrine infusion 3 hours after coronary artery occlusion was not significantly (P>.05) different between basal and apical test sites in each group. infusion) pinacidil. The cumulative percentage of sympathetically nonresponsive apical test sites is shown on the ordinate as a function of time after coronary artery occlusion. Numbers outside the parentheses indicate the cumulative number of nonresponsive test sites (total number of test sites that showed shortening of effective refractory period <2 milliseconds at least once by that moment of determination); the numbers in parentheses indicate the number of test sites that showed nonresponsiveness at that particular time of determination. The cumulative percentage of nonresponsive apical sites in the low-dose pinacidil group was the same as in the vehicle group. The cumulative percentage of nonresponsive apical sites in the medium-dose pinacidil group was similar to that in the pinacidil group. The format is as in Fig 3. the vehicle, glibenclamide (0.3 mg* kg-1 IV), and highand low-dose glibenclamide groups (Fig 6) and in the vehicle, pinacidil (0.15 mg. kg-1 IV+0.2 mg -kg1. h1 IV), and mediumand low-dose pinacidil groups (Fig 7) . The cumulative percentage of sympathetically nonresponsive apical sites in the high-dose glibenclamide group was higher than that in the vehicle group (P=.024) and in the low-dose glibenclamide group (P<.05) but similar to that in the glibenclamide group. The cumulative percentage of sympathetically nonresponsive apical sites was similar between the low-dose glibenclamide and vehicle groups (Fig 6) . The cumulative percentage of sympathetically nonresponsive apical sites in the low-dose pinacidil group was higher than that in the pinacidil group (P=.001) and similar to that in the vehicle group (P=.716). The cumulative percentage of sympathetically nonresponsive apical sites in the medium-dose pinacidil group was less than that in the vehicle and low-dose pinacidil group, but the changes were not significant (Fig 7) .
Protocol 2: Effects of Various Doses of Glibenclamide and Pinacidil on Sympathetic Denervation After Acute Coronary Artery Occlusion
Protocol 3: Effects of Glucose Infusion on Sympathetic Denervation After Acute Coronary Artery Occlusion
Blood glucose values during intravenous glucose infusion are shown in Table 2 . Blood glucose values were similar between the vehicle and glibenclamide with glucose infusion groups. In the dogs that received 0.3 mg * kg-1 glibenclamide with glucose infusion, 1 of 25 apical sites exhibited sympathetic nonresponse 5 minutes after coronary artery occlusion, and sites became sympathetically nonresponsive over a 3-hour period. The cumulative percentage of sympathetically nonresponsive apical test sites in the glibenclamide with glucose infusion group was the same (P=.948) as in the glibenclamide group and greater (P=.024) than in the vehicle group (Fig 6) .
Hemodynamics and Infarct Size
Heart rate, mean arterial pressure, and rate-pressure product data are summarized in Table 3 . Three dogs (two in the glibenclamide group and one in the pinacidil group) developed an atrial rhythm after the sinus node was crushed that was faster than 100 beats per minute. Therefore, the atrial pacing rate was 120 beats per minute in these three dogs. Mean arterial pressure was similar (P>.05) among vehicle, glibenclamide, and pinacidil-balloon groups throughout the sustained coronary artery occlusion. In the pinacidil and glibenclamide+pinacidil group, mean arterial pressure after drug was significantly decreased compared with control values and was less than in the vehicle group during coronary artery occlusion. Mean arterial pressure was decreased by 15.7±2.7 mm Hg 20 minutes after pinacidil administration in the pinacidil group (P<.001 versus before drug) and by 7.6±2.3 mm Hg in the glibenclamide+pinacidil group (P<.02 versus before drug, P<.05 versus pinacidil group). In the pinacidilballoon group, balloon inflation increased mean arterial pressure but did not change mean left atrial pressure (5.9±0.3 versus 5.8±0.4 mm Hg before and after balloon inflation, respectively). Balloon inflation distal to the renal arteries did not affect arterial blood gases and plasma K+. The rate-pressure product was the same in the glibenclamide and in the pinacidil-balloon groups as in the vehicle group immediately before occlusion and during sustained coronary artery occlusion. However, the pinacidil group showed a smaller (P<.05) rate-pressure product compared with the vehicle group after pinacidil administration and over a 3-hour period. The glibenclamide+pinacidil group showed a decreased (P<.05) rate-pressure product compared with the vehicle group before and at 180 minutes after coronary artery occlusion.
Medium-dose pinacidil reduced the mean arterial blood pressure, but the mean arterial blood pressure and the rate-pressure product were similar to the values found in the vehicle group. Mean arterial blood pressure and rate-pressure product were similar among the highand low-dose glibenclamide, low-dose pinacidil, and vehicle groups.
All dogs had transmural myocardial infarctions that involved the epicardium to a similar degree: 11.0+1.4%, 11.8±3.1%, 10.6+1.4%, 9.6±1.1%, and 10.5±1.7% in the vehicle, glibenclamide, pinacidil, glibenclamide+pinacidil, and pinacidil-balloon groups, respectively. Subepicardial infarct size was also similar among the highand low-dose glibenclamide and mediumand low-dose pinacidil groups (9.7±1.5%, 11.6±3.6%, 9. 4+1.5%, and 9.2+2.5%, respectively). The glibenclamide+glucose infusion group showed a subepicardial infarct size (9.9±1.7%) similar to that found in the vehicle and glibenclamide groups.
Protocol 4: Effects of Epicardial Superfusion With Glibenclamide and Pinacidil on ERP Response to Stimulation of Ansae Subclaviae
Values were constant throughout three 60-minute periods of superfusion in all groups (Table 4 ). Fig 8 shows that in the control group, three instillations of NT did not affect AERP induced by bilateral stimulation of the ansae subclaviae. Superfusion with glibenclamide and pinacidil in NT also did not affect AERP induced by stimulation of the ansae subclaviae. Superfusion with CT reduced the ERP response to stimulation of the ansae subclaviae.27,28 Neither glibenclamide nor pinacidil in CT significantly altered the attenuation of AERP in response to stimulation of the ansae subclaviae produced by CT alone. AERP induced by stimulation of the ansae subclaviae was restored after removal of these solutions from the pericardial cavity and instillation of NT. The frequency of sympathetically nonresponsive sites during superfusion with each solution is shown in Table 5 . Numbers of sympathetically nonresponsive test sites were similar among CT, CT+glibenclamide, and CT+pinacidil dogs. 
Discussion
Major Findings
The major observations from the present study are as follows: (1) The KATP channel opener pinacidil helped to preserve the efferent sympathetic response in ventricu-lar myocardium apical to an area of transmural ischemia/infarction. Prevention of pinacidil-induced decreases in arterial pressure or rate-pressure product did not alter the cumulative percentage of sympathetically nonresponsive apical test sites after coronary artery occlusion. The KATP channel blocker glibenclamide in- creased the extent of efferent sympathetic attenuation in ventricular myocardium apical to an area of transmural ischemia/infarction and blunted the beneficial effects of pinacidil on efferent sympathetic attenuation. (2) Such effects of glibenclamide and pinacidil on sympathetic attenuation after acute coronary artery occlusion were dose dependent. (3) Glibenclamide-induced decreases in blood glucose concentration did not appear to be important, since the cumulative percentage of sympathetically nonresponsive apical test sites was similar between dogs receiving glucose infusion to prevent hypoglycemia and dogs with hypoglycemia. (4) Neither glibenclamide nor pinacidil changed the size of the subepicardial infarction 3 hours after latex-induced coronary artery occlusion. (5) Instillation into the pericardial sac of glibenclamide and pinacidil in NT exerted no effect on ERP responses to sympathetic stimulation and did not affect attenuation of efferent sympathetic response during pericardial superfusion with CT. Therefore, KATP channel modulators probably had no the extent of sympathetic attenuation at nonischemic sites apical to the area of myocardial ischemia/infarction without changing the extent of epicardial involvement by myocardial infarction.
Ischemia and KATP Channel Modulators
Glibenclamide, by blocking KATP channels, decreases the action potential shortening during ischemia24 and could contribute to intracellular Ca2' overload,44 with acceleration of ischemic cell death. 45 In contrast, pinacidil activates the KATP channels,l1011'9,4647 increases the open probability of the channels, and could be expected to accelerate the opening of KATP channels that occurs during severe ischemic conditions.11,48 Such shortening of action potential duration could decrease the Ca 2+ current20 associated with cell contraction. Because such contraction helps consume high-energy phosphate stores,17 a reduction in contraction may reduce the rate of decline in [ATP]i and protect against ischemic cell death. 8 Recently, Cole et al,23 using isolated guinea pig right ventricular walls, showed that glibenclamide enhanced, whereas pinacidil reduced, myocardial damage caused by ischemia/reperfusion injury. Grover and col-leagues22'49 reported that pinacidil and cromakalim had direct cardioprotective effects, whereas glibenclamide blocked the beneficial action of KATP channel openers, both in isolated globally ischemic rat hearts and in anesthetized dogs. These protective effects of KATP channel openers were independent of changes in coronary blood flow during ischemia and appeared to be mediated by KATP channels of cardiac myocytes. 22, 24, 49 
Effects of KATP Channel Modulators on Sympathetic Responsiveness: Potential Mechanisms
We have suggested that sympathetic attenuation in nonischemic myocardium apical to an area of ischemia/ infarction may be due, at least in part, to neural dysfunction from the accumulation of ischemic metabolites, such as increases in extracellular K', in myocardium in which the nerve axons lie.4'28 It would seem paradoxical, then, that a KATP channel opener, pinacidil, would decrease the extent of sympathetic attenuation, whereas a KATP channel blocker, glibenclamide, would increase it.
One possible explanation might be if these drugs affected sympathetic nerves directly, particularly since KATP channels have been demonstrated in central neurons. 25 Although glibenclamide blocks the hyperpolarization of nerve cells during hypoxia,50 it has not been shown to exert direct effects on sympathetic neurotransmission. Pinacidil inhibits electrically stimulated overflow of norepinephrine and dopamine in rat vas deferens at serum concentrations exceeding 5 ,umol/L. 51 However, in the present study, we showed that instillation of NT containing glibenclamide and pinacidil into the pericardial sac did not affect the sympathetically induced AERP. In addition, intravenous administration of glibenclamide and pinacidil did not change sympathetic responsiveness of the myocardium at basal and apical test sites before coronary artery occlusion. Finally, efferent sympathetic attenuation during pericardial superfusion with Tyrode's solution containing high K+, low pH, and adenosine2728 was not affected by during the initial period of acute ischemia. This does not seem likely from our data because attenuation of the sympathetic response in the glibenclamide group was similar to that found in the vehicle group during the initial period of ischemia (5 minutes after coronary artery occlusion).
Although we found no published data on whether pinacidil alters [K+]O in vivo, another KATP channel opener, nicorandil in concentrations of 200 ,umol/L, increases the initial rise of [K']O during global ischemia in isolated rat hearts but does not affect the later rise of [K+]0.60 However, as with the glibenclamide responses, this action by pinacidil seems unlikely in the present study because we found that attenuation of sympathetic responsiveness in the pinacidil-treated dogs was comparable to that noted in dogs treated with vehicle during the initial period of acute ischemia (5 minutes after coronary artery occlusion).
The differences in sympathetic responsiveness produced by glibenclamide and pinacidil occurred during the later stages of ischemia, when [K+]O is due to irreversible cell membrane damage.61 KATP channel openers reduce the ischemic release of lactate dehydrogenase, which reflects myocardial injury.22'49,62-64 Glibenclamide reverses such beneficial effects of KATP channel openers.22496263 It is possible that in our model, pinacidil reduced the extent of myocardial dam- .< -5-0-age22,23,49'63 that contributes to the accumulation of ischemic metabolites, such as [K+]0 ,61 [H+], ,65 and adenosine,17 and protected against sympathetic attenuation during later stages of acute myocardial ischemia/infarction. Glibenclamide could have abolished the beneficial effects of pinacidil on sympathetic attenuation by enhancing the ischemic myocardial damage23'24'66,67 and blocking the cardioprotective action of pinacidil. 22, 23, 49 Recently, KATP channels have been proposed to mediate ischemic preconditioning,35 and glibenclamide reverses preconditioning effects by blocking the KATP channels. We have shown previously that preconditioning protects against development of sympathetic attenuation after acute myocardial ischemia/infarction without changing the extent of subepicardial infarct size. 4 The exact mechanisms of preconditioning effects on sympathetic attenuation were unclear. It is possible that activation of KATP channels during ischemia reduced myocardial damage24 and the accumulation of ischemic metabolites, such as K' and H', and protected against sympathetic attenuation.
Neither glibenclamide nor pinacidil affected the size of epicardial involvement by myocardial infarction 3 hours after coronary artery occlusion using latex injection. In other reports, glibenclamide has been shown to increase and pinacidil has been shown to reduce myocardial infarct size.4967 These differences probably depend on the ischemic models, especially the presence of reperfusion in most previous studies.21 '22'24'35'66'67 Glibenclamide reduces68-70 and pinacidil increases coronary blood flow.71'72 It is unlikely that these drugs affected the ischemic blood flow in our model because latex eliminates collateral flow73 and markedly reduces flow to the ischemic zone.1 The fact that infused norepinephrine shortened ERPs equally at basal sites and apical sites suggests that functioning adrenergic receptors were still present and that there was sufficient blood flow to distribute infused norepinephrine to the apical sites.
Pinacidil decreases afterload and preload and reduces cardiac oxygen consumption by vasodilatation of peripheral resistant vessels72'74; these hemodynamic changes lessen myocardial cell death.72'74 We used balloon inflation distal to the renal arteries to prevent the hypotensive action of pinacidil without increasing left atrial blood pressure. In the balloon-inflated group, subepicardial infarct size was the same as in the other groups, whereas sympathetic attenuation was reduced compared with the vehicle group. These results suggest that reduced arterial pressure or rate-pressure product did not contribute importantly to the sympathetic attenuation after myocardial infarct in the present study.
Pinacidil has direct actions on cells other than KATP channels.4475 Although we cannot exclude this possibility as being responsible for the effects of pinacidil on ischemia-induced sympathetic attenuation, it seems unlikely because glibenclamide markedly attenuated the beneficial effect of pinacidil on sympathetic responsiveness.
Although glibenclamide-induced hypoglycemia did not increase the subepicardial infarct size in the present study, it has been shown that hypoglycemia can increase ischemic myocardial damage.42 Sympathetic attenuation was the same in dogs that received glibenclamide with glucose infusion as in glibenclamide-treated dogs with-out glucose infusion. Accordingly, hypoglycemia did not appreciably alter sympathetic responsiveness after myocardial ischemia/infarction in our experimental model.
In summary, although the perimeter of epicardial involvement by infarction was similar in the pinacidil and glibenclamide groups, the extent of cell death within the infarction and the resultant accumulation of ischemic metabolites at 1 to 3 hours might have been different because of the opposite effects these two drugs exert on infarction models. These differences could explain the different sympathetic responses to the two drugs. Naturally, that conclusion is speculative and requires future testing.
